Among breast cancer samples, mutations were detected in 46.6% of the analyzed tumors, specifically in PIK3CA and KIT. Mutations among other genes were present in less than 5%, a rate similar to those of the COSMIC database and other studies such as The Cancer Genome Atlas Network (See Supplementary Table S3) [21, 28–30]. The gene discussed is PIK3CA; the disease is breast carcinoma.